Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Tech: VC Twitter has found a new love — LinkedIn ... either — and it's all reflected in the current egg prices. 2. Eli Lilly's weight-loss wonders. The Mounjaro and Zepbound producer hopes ...

Five years later, the sheriff’s office is celebrating 77 million impressions, 7 million engagements and nearly 300,000 “likes” on the viral tweet. Along with the impressive metrics, the agency shared ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

And then there was one. HBO set out to chronicle the behind-the-scenes developments of four different teams at once this season with Hard Knocks: In Season With the AFC North, but only the ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

Shares of Eli Lilly (LLY) have dopped to a price level that has been support. The stage may be set for a reversal or move higher. Get access to your new suite of high-powered trading tools ...